Global Thalomid Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Thalomid Market Research Report 2024
Thalidomide, sold under the brand name Thalomid among others, is a medication used to treat a number of cancers including multiple myeloma, graft-versus-host disease, and a number of skin conditions including complications of leprosy.
According to Mr Accuracy reports new survey, global Thalomid market is projected to reach US$ 1004.5 million in 2029, increasing from US$ 523 million in 2022, with the CAGR of 8.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thalomid market research.
Thalomid (generic namethalidomide) is a pharmaceutical drug that was initially developed as a sedative and anti-nausea medication in the late 1950s and early 1960s. However, it gained notoriety due to its severe teratogenic effects, causing birth defects in children born to mothers who took the drug during pregnancy. Thalidomide was subsequently withdrawn from the market in many countries.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Thalomid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Celgene
Segment by Type
50mg
100mg
200mg
Retail Pharmacy
Hospital Pharmacy
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Thalomid report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Thalomid market is projected to reach US$ 1004.5 million in 2029, increasing from US$ 523 million in 2022, with the CAGR of 8.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thalomid market research.
Thalomid (generic namethalidomide) is a pharmaceutical drug that was initially developed as a sedative and anti-nausea medication in the late 1950s and early 1960s. However, it gained notoriety due to its severe teratogenic effects, causing birth defects in children born to mothers who took the drug during pregnancy. Thalidomide was subsequently withdrawn from the market in many countries.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Thalomid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Celgene
Segment by Type
50mg
100mg
200mg
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Thalomid report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source